Table 2 Surgical outcomes for female patients
Variables | Extracorporeal (n = 19) | Intracorporeal (n = 19) | P |
|---|---|---|---|
Diversion type, n (%) | 0.737 | ||
Ileal conduit | 11 (58%) | 13 (68%) | |
Neobladder | 8 (42%) | 6 (32%) | |
Operative time (mean ± SD), min | 364.6 ± 72.30 | 297.1 ± 48.24 | 0.007 |
EBL (mean ± SD), mL | 393.1 ± 387.46 | 267.0 ± 205.69 | 0.252 |
Transfusion, n (%) | 7 (37%) | 1 (5%) | 0.042 |
ICU stay after surgery, n (%) | 2 (10%) | 1 (5%) | > 0.9 |
Time to flatus (median [range]), days | 5 [3–9] | 3 [1–6] | 0.020 |
Time to intake of liquid diet (median [range]), days | 5 [4–8] | 4 [2–18] | 0.087 |
Time to ambulation (median [range]), days | 2 [0–5] | 1 [1–3] | 0.022 |
Time to remove Jackson-Pratt drain (median [range]), days | 14 [5–23] | 10 [4–30] | 0.549 |
Length of hospital stay after surgery (median [range]), days | 22 [14–45] | 13 [7–22] | 0.002 |
Final pathologic stage | 0.527 | ||
Ta/T1/Tis | 10 (53%) | 9 (47%) | |
T2 | 6 (32%) | 4 (21%) | |
T3 | 2 (10%) | 5 (26%) | |
T4 | 1 (5%) | 1 (5%) | |
Pathologic stage | 0.631 | ||
N0 | 13 (68%) | 13 (68%) | |
N1 | 3 (16%) | 0 (0%) | |
N2 | 3 (16%) | 3 (16%) | |
N3 | 0 (0%) | 3 (16%) | |
Lymph node yield (mean ± SD), n | 12.9 ± 7.81 | 18.6 ± 11.51 | 0.140 |
Lymph node positive patients, n (%) | 7 (37%) | 6 (32%) | > 0.9 |
Positive surgical margin, n (%) | 2 (11%) | 4 (21%) | 0.660 |